Cian Healthcare Ltd (BSE: 542678) is a Pune, Maharashtra-based company in the Pharmaceutical Contract Manufacturing Services industry. With a market capitalisation of ₹70 Cr, it ranks #3,574 by market cap among the 6,137 Indian listed companies on FinBizNet, and #18 of 26 in Pharmaceutical Contract Manufacturing Services. At ₹28.62 (as of 25 Oct 2026), the share price is 73.9% below its 52-week high of ₹109.62 and 263.7% above its 52-week low of ₹7.87. The share price is down 64.5% over one year and up 217.9% over three months.
| Current Price | ₹28.62 |
|---|---|
| Market Cap | ₹70 Cr |
| BSE Code | 542678 |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Pharmaceuticals > Pharmaceutical Contract Manufacturing Services |
| P/E Ratio | -3.1 |
| Return on Equity | -57.29% |
| Return on Assets | -6.06% |
| 52-Week Range | ₹7.87 – ₹109.62 |
| 1-Year Price Change | -64.5% |
| 3-Month Price Change | +217.9% |
| Beta (1Y) | 1.03 |
| Headquarters | Pune, Maharashtra |
| Website | cian.co |
Cian Healthcare Limited engages in the research, development, manufacture, marketing, and sale of pharmaceutical products in India. It offers pharmaceutical products in various therapeutic areas of gynecology, haematinic, cardio- diabetic, orthopedic, pediatric, dermacosmetic, antibiotic, CNS, and vitamins and nutrient products. The company also provides male and female infertility, reproductive wellness, energy boosting, autism, multivitamins, joint care products, and haematinic products, as well as face and hair serums, veterinary products, and cosmetics. It offers its products in the form of tablets, capsules, soft gels, liquid orals, ointments/ creams and sachets, and cosmetics. The company exports its products to various countries, such as Afghanistan, Benin, Bhutan, Bolivia, Cambodia, Sri Lanka, and Myanmar. The company was incorporated in 2003 and is based in Pune, India.
1. Developing Unique Formulations in Healthcare and Nutraceutical-This segment develops formulations in healthcare and nutraceutical areas.
1. Pharmaceuticals-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Torrent Pharma Ltd. | ₹1,73,448 Cr | 71.2 | 16.98% | ₹4,979 Cr | +28.0% |
| Aether Industries Limited | ₹20,419 Cr | 92.1 | 9.81% | ₹327 Cr | +88.8% |
| Alivus Life Sciences Ltd | ₹16,073 Cr | 27.7 | 18.36% | ₹640 Cr | +33.8% |
| Aarti Pharmalabs Ltd | ₹7,922 Cr | 43.2 | 8.49% | ₹536 Cr | -4.1% |
| Solara Active Pharma Sciences Limited | ₹3,361 Cr | -382.6 | -0.63% | ₹417 Cr | +3.3% |
| Sai Parenteral's Limited | ₹2,153 Cr | 110.9 | 2.88% | ₹179 Cr | — |
| KRM Ayurveda Limited | ₹556 Cr | 25.9 | — | ₹32 Cr | — |
| Trident Lifeline Limited | ₹501 Cr | 24.8 | — | — | +39.4% |
| Cian Healthcare Ltd | ₹70 Cr | -3.1 | -57.29% | — | -64.5% |
Listed by market capitalisation. Ratios are shown for context only.
Cian Healthcare Ltd is trading at ₹28.62, with a market capitalisation of ₹70 Cr.
Cian Healthcare Ltd operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Pharmaceutical Contract Manufacturing Services).
Cian Healthcare Ltd has a P/E of -3.1 and a return on equity of -57.29%.
Cian Healthcare Ltd is listed on the BSE under the scrip code 542678.
Cian Healthcare Ltd's share price is down 64.5% over one year and up 217.9% over three months. Its 52-week range is ₹7.87 to ₹109.62.
Data as of 25 Oct 2026. Descriptive market data only — not investment advice.